Misuse of Drugs Act
Drugs Subject to Temporary Control
3D rendering of 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
Effective 5 Apr 2012, S.I. 2012/980 added, for one year’s duration:
2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone (Methoxetamine)
  • (a) 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
  • (b) any stereoisomeric form of 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
  • (c) any ester or ether of a substance specified in paragraph (a) or (b);
  • (d) any salt of a substance specified in any of paragraphs (a) to (c); and
  • (e) any preparation or other product containing a substance specified in any of paragraphs (a) to (d).
EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
UK: Currently at MDA Part II Class B Section 1(d) Methoxetamine
⇒
PubChem: 52911279; ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1.
The following substances, namely—
3D rendering of 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
US: CSA Schedule I Section h Subsection 4 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 10251906; ChemSpider: 8427392; Bluelight: 25I-NBOMe; Drugs Forum: 25I-NBOMe; Erowid: 25I-NBOMe; Wikipedia: 25I-NBOMe
3D rendering of 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: CSA Schedule I Section h Subsection 6 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 9977044; ChemSpider: 8152636; Bluelight: 25B-NBOMe; Drugs Forum: 25B-NBOMe; Wikipedia: 25B-NBOMe
3D rendering of 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: Currently at MDA Part I Class A Section 1(f) 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
ChemSpider: 29341727; Drugs Forum: 25D-NBOMe; Wikipedia: 25D-NBOMe
3D rendering of 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: CSA Schedule I Section h Subsection 5 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 46856354; ChemSpider: 24583389; Bluelight: 25C-NBOMe; Drugs Forum: 25C-NBOMe; Erowid: 25C-NBOMe; Wikipedia: 25C-NBOMe
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
2.
The following substances, namely—
3D rendering of 1-(Benzofuran-5-yl)-propan-2-amine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(Benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives
UK: Currently at MDA Part II Class B Section 1(e) 1-(Benzofuran-5-yl)-propan-2-amine
⇒
PubChem: 9837232; ChemSpider: 8012953; Drugs Forum: 5-APB; Wikipedia: 5-APB
3D rendering of 1-(Benzofuran-6-yl)-propan-2-amine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(Benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives
UK: Currently at MDA Part II Class B Section 1(e) 1-(Benzofuran-6-yl)-propan-2-amine
⇒
PubChem: 9794343; ChemSpider: 7970110; Bluelight: 6-APB; Drugs Forum: 6-APB; Erowid: 6-APB; Wikipedia: 6-APB
3D rendering of 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives
UK: Currently at MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
⇒
PubChem: 192601; ChemSpider: 167143; Drugs Forum: 5-APDB; Wikipedia: 5-APDB
3D rendering of 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives
UK: Currently at MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
⇒
PubChem: 192599; ChemSpider: 167141; Wikipedia: 6-APDB
3D rendering of 1-(1H-Indol-5-yl)-1-methylethylamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(1H-Indol-5-yl)-1-methylethylamine
EU: Substances Substances 5-(2-Aminopropyl)indole
UK: Currently at MDA Part II Class B Section 1(e) 1-(1H-Indol-5-yl)-1-methylethylamine
⇒
PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
3D rendering of 1-(1H-Indol-6-yl)-1-methylethylamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
1-(1H-Indol-6-yl)-1-methylethylamine
UK: Currently at MDA Part II Class B Section 1(e) 1-(1H-Indol-6-yl)-1-methylethylamine
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
3.
Any stereoisomeric form of a substance specified in paragraph 1 or 2.
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
4.
Any salt of a substance specified in any of paragraphs 1 to 3.
Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
5.
Any preparation or other product containing a substance specified in any of paragraphs 1 to 4.
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
1.
The following substances, namely—
3D rendering of 3,4-Dichloromethylphenidate
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
3,4-Dichloromethylphenidate (3,4-DCMP)
See also MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
⇒
PubChem: 44418862; ChemSpider: 23278471; Wikipedia: 3,4-Dichloromethylphenidate
3D rendering of Ethylphenidate
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
Ethylphenidate
See also MDA Temporary Class Drug Orders 2015 Ethylphenidate
⇒
PubChem: 3080846; ChemSpider: 2338571; Drugs Forum: Ethylphenidate; Erowid: Ethylphenidate; Wikipedia: Ethylphenidate
3D rendering of Isopropylphenidate
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
Isopropylphenidate (IPP; IPPD)
See also MDA Temporary Class Drug Orders 2015 Isopropylphenidate
⇒
PubChem: 68314762; Wikipedia: Isopropylphenidate
3D rendering of Methylnaphthidate
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
Methylnaphthidate (HDMP-28)
See also MDA Temporary Class Drug Orders 2015 Methylnaphthidate
⇒
PubChem: 49823708; ChemSpider: 24818258; Wikipedia: HDMP-28
3D rendering of Propylphenidate
Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
Propylphenidate
See also MDA Temporary Class Drug Orders 2015 Propylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
1.
The following substances, namely—
With thanks to Niflheim for pointing out all of S.I. 2015/1396 had been missed—note the impersonal passive construction suggesting an act of God ;)
3D rendering of 3,4-Dichloromethylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
3,4-Dichloromethylphenidate (3,4-DCMP)
See also MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
⇒
PubChem: 44418862; ChemSpider: 23278471; Wikipedia: 3,4-Dichloromethylphenidate
3D rendering of 4-Methylmethylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
4-Methylmethylphenidate
⇒
PubChem: 44296147; ChemSpider: 8281556; Wikipedia: 4-Methylmethylphenidate
3D rendering of Ethylnaphthidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
Ethylnaphthidate
⇒
PubChem: 91844468; Wikipedia: HDEP-28
3D rendering of Ethylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
Ethylphenidate
See also MDA Temporary Class Drug Orders 2015 Ethylphenidate
⇒
PubChem: 3080846; ChemSpider: 2338571; Drugs Forum: Ethylphenidate; Erowid: Ethylphenidate; Wikipedia: Ethylphenidate
3D rendering of Isopropylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
Isopropylphenidate (IPP; IPPD)
See also MDA Temporary Class Drug Orders 2015 Isopropylphenidate
⇒
PubChem: 68314762; Wikipedia: Isopropylphenidate
3D rendering of Methylnaphthidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
Methylnaphthidate (HDMP-28)
See also MDA Temporary Class Drug Orders 2015 Methylnaphthidate
⇒
PubChem: 49823708; ChemSpider: 24818258; Wikipedia: HDMP-28
3D rendering of Propylphenidate
Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
Propylphenidate
See also MDA Temporary Class Drug Orders 2015 Propylphenidate
3D rendering of N-Methyl-1-(thiophen-2-yl)propan-2-amine
Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
(a)
N-Methyl-1-(thiophen-2-yl)propan-2-amine (Methiopropamine; MPA);
⇒
PubChem: 436156; ChemSpider: 385727; Erowid: Methiopropamine; Wikipedia: Methiopropamine
Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
(b)
any stereoisomeric form of N-Methyl-1-(thiophen-2-yl)propan-2-amine;
Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
(c)
any salt of a substance specified in paragraph (a) or (b); and
Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
(d)
any preparation or other product containing a substance specified in any of paragraphs (a) to (c).
11 March 2016 · Creative Commons BY-NC-SA ·